This guideline sets out an antimicrobial prescribing strategy for managing Clostridioides difficile infection in adults, young people and children aged 72 hours and over in community and hospital settings. It aims to optimise antibiotic use and reduce antibiotic resistance. The recommendations do not cover diagnosis.
Evidence-based recommendations on onasemnogene abeparvovec (Zolgensma) for treating spinal muscular atrophy in babies
Publications approval reference: 001559 NHS England and NHS Improvement Specialty guides for patient management during the COVID-19 pandemic Clinical
Publications approval reference: 001559 1 | Clinical guide for the management of emergency department patients during the coronavirus pandemic